Displaying drugs 301 - 325 of 2785 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Birch bark extract | Not Available | A herbal medicinal product used to treat partial thickness wounds. | Anti-Inflammatory Agents / Anti-inflammatory Agents, Miscellaneous / Biological Products / Complex Mixtures / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 Enzyme Inhibitors / Plant Preparations / Triterpenes / Wound Healing | |
Bisacodyl | 361.3906 C22H19NO4 | A stimulant laxative used for the temporary relief of occasional constipation and cleansing of the colon as a preparation for colonoscopy in adults. | Enemas | |
Bismuth subcitrate potassium | 780.654 C12H8BiK5O14 | A colloid used for the treatment of peptic ulcer and gastro-esophageal reflux disease (GERD). | Neurotoxic agents | |
Bismuth subgallate | 394.091 C7H5BiO6 | A medication used to deodorize flatulence and stools as well as hemostasis in soft tissue surgery. | Neurotoxic agents | |
Bismuth subnitrate | 1461.98 Bi5H9N4O22 | A medication used as an antacid. | Neurotoxic agents | |
Bismuth subsalicylate | 362.0926 C7H5BiO4 | An antidiarrheal and anti-inflammatory agent used for symptomatic treatment of nausea, indigestion, upset stomach, diarrhea, and other temporary discomforts of the stomach and gastrointestinal tract. | Neurotoxic agents | |
Bisoctrizole | 658.891 C41H50N6O2 | An absorber of UVA and UVB radiation used in sunscreen. | Sunscreen Agents | |
Bisoprolol | 325.443 C18H31NO4 | A beta-1 adrenergic blocking agent used to prevent myocardial infarction and heart failure and to treat mild to moderate hypertension. | Antihypertensive Agents / Beta blocking agents and calcium channel blockers / Beta Blocking Agents, Selective / Beta Blocking Agents, Selective, and Thiazides | |
Bisoxatin | 333.343 C20H15NO4 | For use in the treatment of constipation in the absence of bowel obstruction and for surgical preparation of the colon . | Contact Laxatives | |
Bisphenol A diglycidyl ether | 340.4129 C21H24O4 | Not Annotated | Carcinogens / Standardized Chemical Allergen | |
Bithionol | 356.052 C12H6Cl4O2S | Bithionol, formerly marketed as an active ingredient in various topical drug products, was shown to be a potent photosensitizer with the potential to cause serious skin disorders. Approvals of the... | Preparations Containing Sulfur | |
Bivalirudin | 2180.2853 C98H138N24O33 | A direct thrombin inhibitor used to treat heparin-induced thrombocytopenia and to prevent thrombosis during percutaneous coronary intervention. | Anticoagulants / Antithrombins | |
Bleomycin | 1415.552 C55H84N17O21S3 | A chemotherapy agent used to treat various malignancies, including head and neck malignancy, lymphoma, and testicular tumors, among others. | Antibiotics, Antineoplastic / Cytoprotective Agent / Glycopeptides | |
Boceprevir | 519.6767 C27H45N5O5 | A hepatitis C virus NS3/4A protease inhibitor used in combination with other medications to treat chronic hepatitis C genotype 1 infection. Boceprevir is not indicated as monotherapy. | Antivirals for treatment of HCV infections / Protease Inhibitors | |
Boric acid | 61.833 BH3O3 | No FDA- or EMA-approved therapeutic indications on its own. | Anti-Infective Agents | |
Bortezomib | 384.237 C19H25BN4O4 | A proteasome inhibitor used to treat multiple myeloma in patients who have not been successfully treated with at least two previous therapies. | Boronic Acids / Proteasome Inhibitors / Pyrazines | |
Bortezomib D-mannitol | 530.39 C25H35BN4O8 | Not Annotated | Proteasome Inhibitors | |
Boscalid | 343.207 C18H12Cl2N2O | Boscalid has been investigated for the treatment of OSDI, Glaucoma, Staining, Schirmers, and Disease Severity, among others. | Benzene Derivatives / Nicotinic Acids / Pyridines | |
Bosentan | 551.614 C27H29N5O6S | A dual endothelin receptor antagonist used to treat pulmonary arterial hypertension. | Antihypertensives for Pulmonary Arterial Hypertension / Sulfonamides | |
Bosutinib | 530.446 C26H29Cl2N5O3 | An antineoplastic agent used for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adults with inadequate clinical response to other treatments. | Bcr-Abl Tyrosine Kinase Inhibitors / Protein Kinase Inhibitors | |
Bretylium | 243.163 C11H17BrN | A norepinephrine release inhibitor used for the prophylaxis and therapy of ventricular fibrillation, as well as the treatment of life-threatening ventricular arrhythmias. | Adrenergic Antagonists / Antiarrhythmic agents / Antiarrhythmics, Class III / Antihypertensive Agents / Bretylium Compounds | |
Brexanolone | 318.4935 C21H34O2 | Brexanolone is a synthetic neuroactive steroid gamma-aminobutyric acid A (GABA(a)) receptor positive modulator indicated for the treatment of postpartum depression (PPD) in adult women [FDA Label][A176080, A176083, F4063, F4066, F4072]. | Anesthetics / Anticonvulsants / GABA Modulators / Neurotransmitter Agents | |
Brexpiprazole | 433.57 C25H27N3O2S | A serotonin–dopamine activity modulator used in the treatment of major depressive disorder as an adjunct, schizophrenia, and agitation associated with dementia due to Alzheimer’s disease. | Agents that produce hypertension / Neurotoxic agents | |
Brigatinib | 584.1 C29H39ClN7O2P | An anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer. | Anaplastic lymphoma kinase (ALK) inhibitors / Protein Kinase Inhibitors | |
Brilliant blue G | 854.02 C47H48N3NaO7S2 | A disclosing agent used in ophthalmological surgery to stain the internal limiting membrane (ILM). | Indicators and Reagents |
Displaying drugs 301 - 325 of 2785 in total